Hormone therapy: The European women's perspective

Climacteric

Volumn 6, Issue 4, 2003, Pages 337-346

  Strothmann, A ^a   Schneider, H P G ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Duration; Hormone therapy; Knowledge; Menopause; Prevalence; Women

Indexed keywords

HORMONE;

ADULT; AGED; ANAMNESIS; AWARENESS; BLOOD CLOTTING; BREAST CANCER; CANCER RISK; COMPUTER; CONTROLLED STUDY; DRUG USE; EUROPE; FEMALE; GENERAL CONDITION IMPROVEMENT; HEALTH SURVEY; HORMONAL THERAPY; HOT FLUSH; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MENOPAUSAL SYNDROME; OSTEOPOROSIS; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SCIENCE; STANDARDIZATION; SYMPTOMATOLOGY; TELEPHONE; THROMBOSIS; WEIGHT GAIN; WELLBEING;

EID: 1642477810     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/cmt.6.4.337.346     Document Type: Review

References (42)

1. World Bank data, 2001
2. Treloar AE. Menstrual cyclicity and the premenopause. Maturitas 1981;3:249-64
3. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992;14:103-15
4. Scalley EK, Henrich JB. An overview of estrogen replacement therapy in postmenopausal women. J Women's Health 1993;2:289-94
5. Sourander E, Rajala T, Räihä I, Mäkinen J, Erkkola R, Helenius H. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT). Lancet 1998;352:1965-9
6. Barrett-Connor E. Hormone replacement therapy. Br Med J 1998;317:457-61
7. Sullivan JM, Fowlkes LP. The clinical aspects of estrogen and the cardiovascular system. Obstet Gynecol 1996;87:36-43s
8. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-32
9. Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. J Am Med Assoc 2002;288:2123-9
10. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. J Am Med Assoc 1998;279:688-95
11. Fillit H. The role of hormone replacement therapy in the prevention of Alzheimer disease. Arch Intern Med 2002;162:1934-42
12. Henderson VW. Estrogen, cognition, and a woman's risk of Alzheimer disease. Am J Med 1997;103:11-17s
13. Gambacciani M, Ciaponi M, Cappagli B, et al. Effects of low-dose, continuous combined estradiol and norethisterone acetate on menopausal quality of life in early postmenopausal women. Maturitas 2003;44:157-63
14. Rossouw JE, Anderson GL, Prentice RE, et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-33
15. Clinkingbeard C, Minton BA, Davis J, McDermott K. Women's knowledge about menopause, hormone replacement therapy (HRT), and interactions with Healthcare providers: an exploratory study. J Womens Health Gend Based Med 1999;8:1097-102
16. Schneider HPG. Cross-national study of women's use of hormone replacement therapy (HRT) in Europe. Int J Fertil Womens Med 1997;42(Suppl 2):365-75
17. Lewin KJ, Sinclair HK, Bond CM. Women's knowledge of and attitudes towards hormone replacement therapy. Fam Pract 2003;20:112-19
18. Schneider HPG, Dören M. Traits for long-term acceptance of hormone replacement therapy - results of a representative German survey. Eur Menopause J 1996;3(Suppl 2):94-8
19. Million Women Study Collaborators. Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000. Br J Obstet Gynaecol 2002;109:1319-30
20. Chiaffarino F, Parazzini F, La Vecchia C, et al. Correlates of hormone replacement therapy use in Italian women, 1992-1996. Maturitas 1999;33:107-15
21. Breslau ES, Davis WW, Doner L, et al. The hormone therapy dilemma: women respond. J Am Med Womens Assoc 2003;58:33-43
22. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998;280:605-13
23. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002 21;360:942-4
24. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-27
25. Gabler S, Haeder S. Überlegungen zu einem Stichprobendesign für Telefonumfragen in Deutschland. ZUMA-Nachrichten 1997;41:7-18
26. Oddens BJ, Boulet MJ, Lehert P, Visser AP. Has the climacteric been medicalized? A study on the use of medication for climacteric complaints in four countries. Maturitas 1992;15:171-81
27. Groeneveld FP, Bareman FP, Barentsen R, Dokter HJ, Drogendijk AC, Hoes AW. Duration of hormonal replacement therapy in general practice; a follow-up study. Maturitas 1998;29:125-31
28. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536-45
29. Jannausch M, Sowers M. Consistency of perimenopausal estrogen use reporting by women in a population-based prospective study. Maturitas 1992;14:161-9
30. Castel-Branco C, Figueras F, Sanjuan A, et al. Long-term compliance with estrogen replacement therapy in surgical postmenopausal women: benefits to bone and analysis of factors associated with discontinuation. Menopause 1999;6:307-11
31. Li C, Samsioe G, Lidfelt J, Nerbrand C, Agardh CD; Women's Health in Lund Area (WHILA) Study. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study. Menopause 2000;7:273-81
32. Vihtamaki T, Savilahti R, Tuimala R. Why do postmenopausal women discontinue hormone replacement therapy? Maturitas 1999;33:99-105
33. Jensen LB, Vestergaard P, Hermann AP, et al. Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study. J Bone Miner Res 2003;18:333-42
34. Guthrie JR, Dennerstein L, Dudley EC. Weight gain and the menopause: a 5-year prospective study. Climacteric 1999;2:205-11
35. Davies KM, Heaney RP, Recker RR, Barger-Lux MJ, Lappe JM. Hormones, weight change and menopause. Int J Obes 2001;25:874-79
36. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998;19:61-109
37. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. J Am Med Assoc 2003;289:3243-53
38. Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. J Am Med Assoc 2003;289:2673-84
39. Manson JE, Hsia J, Johnson KC, et al. Women's Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-34
40. Shumaker SA, Legault C, Rapp SR, et al. WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomised controlled trial. J Am Med Assoc 2003;289:2651-62
41. Rapp SR, Espeland MA, Shumaker SA, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. J Am Med Assoc 2003;289:2663-72
42. Hays J, Ockene JK, Brunner RL, et al. Women's Health Initiative Investigators. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839-54